Reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.

<h4>Background</h4>Transparent and complete publications of randomised controlled trials (RCT) ought to comply with the guidelines of the CONSORT Statement, which stipulates sample size calculation as an important aspect of trial planning. The objective of this study was to analyse and c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sabrina Tulka, Stephanie Knippschild, Sina Funck, Isabelle Goetjes, Yasmin Uluk, Christine Baulig
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4eee9e82cc984651a3c39f8c24b48b59
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4eee9e82cc984651a3c39f8c24b48b59
record_format dspace
spelling oai:doaj.org-article:4eee9e82cc984651a3c39f8c24b48b592021-12-02T20:11:02ZReporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.1932-620310.1371/journal.pone.0252640https://doaj.org/article/4eee9e82cc984651a3c39f8c24b48b592021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0252640https://doaj.org/toc/1932-6203<h4>Background</h4>Transparent and complete publications of randomised controlled trials (RCT) ought to comply with the guidelines of the CONSORT Statement, which stipulates sample size calculation as an important aspect of trial planning. The objective of this study was to analyse and compare the reporting of statistical sample size calculations in RCT papers on the treatment of age-related macular degeneration (AMD), glaucoma and cataract published in 2018.<h4>Material and methods</h4>This study comprises a total of 113 RCT papers (RCT-P) published in 2018 (AMD: 14, glaucoma: 28, cataract: 71), in English or German, and identified through an internet-based literature search in PubMed and EMBASE. The primary outcome measure of the study was the number of trials providing a complete description of the underlying sample case calculation on the basis of the variables required (significance level, expected outcomes, power, and resulting sample size).<h4>Results</h4>Of the RCTs reviewed, 64% (AMD), 61% (glaucoma) and 31% (cataract) provided a justification of the number of patients included. A complete description of the described studies' sample size calculation including all the necessary values (primary outcome measure of this study) was described by 21% of the AMD, 29% of the cataract and 18% of the glaucoma RCT publications (in total: 24 of 113 (21%) at a confidence interval of 95%: [13%; 29%]).<h4>Conclusion</h4>All three treatment areas analysed lacked reporting quality regarding the justification of the number of patients included in a clinical trial based on a sample size calculation required for ethical reasons. More than half of all RCT publications reviewed did not provide all of the required information on statistical sample size calculation, and thus lacked transparency and completeness. It is therefore urgently required to involve methodologists in a study's planning and publishing processes to ensure that methodology descriptions are transparent and of high quality.Sabrina TulkaStephanie KnippschildSina FunckIsabelle GoetjesYasmin UlukChristine BauligPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0252640 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sabrina Tulka
Stephanie Knippschild
Sina Funck
Isabelle Goetjes
Yasmin Uluk
Christine Baulig
Reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.
description <h4>Background</h4>Transparent and complete publications of randomised controlled trials (RCT) ought to comply with the guidelines of the CONSORT Statement, which stipulates sample size calculation as an important aspect of trial planning. The objective of this study was to analyse and compare the reporting of statistical sample size calculations in RCT papers on the treatment of age-related macular degeneration (AMD), glaucoma and cataract published in 2018.<h4>Material and methods</h4>This study comprises a total of 113 RCT papers (RCT-P) published in 2018 (AMD: 14, glaucoma: 28, cataract: 71), in English or German, and identified through an internet-based literature search in PubMed and EMBASE. The primary outcome measure of the study was the number of trials providing a complete description of the underlying sample case calculation on the basis of the variables required (significance level, expected outcomes, power, and resulting sample size).<h4>Results</h4>Of the RCTs reviewed, 64% (AMD), 61% (glaucoma) and 31% (cataract) provided a justification of the number of patients included. A complete description of the described studies' sample size calculation including all the necessary values (primary outcome measure of this study) was described by 21% of the AMD, 29% of the cataract and 18% of the glaucoma RCT publications (in total: 24 of 113 (21%) at a confidence interval of 95%: [13%; 29%]).<h4>Conclusion</h4>All three treatment areas analysed lacked reporting quality regarding the justification of the number of patients included in a clinical trial based on a sample size calculation required for ethical reasons. More than half of all RCT publications reviewed did not provide all of the required information on statistical sample size calculation, and thus lacked transparency and completeness. It is therefore urgently required to involve methodologists in a study's planning and publishing processes to ensure that methodology descriptions are transparent and of high quality.
format article
author Sabrina Tulka
Stephanie Knippschild
Sina Funck
Isabelle Goetjes
Yasmin Uluk
Christine Baulig
author_facet Sabrina Tulka
Stephanie Knippschild
Sina Funck
Isabelle Goetjes
Yasmin Uluk
Christine Baulig
author_sort Sabrina Tulka
title Reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.
title_short Reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.
title_full Reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.
title_fullStr Reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.
title_full_unstemmed Reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.
title_sort reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/4eee9e82cc984651a3c39f8c24b48b59
work_keys_str_mv AT sabrinatulka reportingofstatisticalsamplesizecalculationsinpublicationsoftrialsonagerelatedmaculardegenerationglaucomaandcataract
AT stephanieknippschild reportingofstatisticalsamplesizecalculationsinpublicationsoftrialsonagerelatedmaculardegenerationglaucomaandcataract
AT sinafunck reportingofstatisticalsamplesizecalculationsinpublicationsoftrialsonagerelatedmaculardegenerationglaucomaandcataract
AT isabellegoetjes reportingofstatisticalsamplesizecalculationsinpublicationsoftrialsonagerelatedmaculardegenerationglaucomaandcataract
AT yasminuluk reportingofstatisticalsamplesizecalculationsinpublicationsoftrialsonagerelatedmaculardegenerationglaucomaandcataract
AT christinebaulig reportingofstatisticalsamplesizecalculationsinpublicationsoftrialsonagerelatedmaculardegenerationglaucomaandcataract
_version_ 1718374944115523584